Exicure, INC 10-Q quarterly reports

Exicure, Inc. reported a net loss of $1.12 million for Q2 2026, with cash reserves insufficient for 12 months of operations, raising substantial doubt about its going concern status.

Exicure reports a net loss of $1.8 million for Q1 2026 and warns of substantial doubt regarding its ability to continue as a going concern.

Exicure, Inc. reported an increased net loss for Q3 2025 and expressed substantial doubt about its ability to continue as a going concern, despite strategic shifts into new biotechnology and entertainment ventures.

Exicure, Inc. reports a net income for the six months ended June 30, 2025, driven by a significant lease termination gain, but faces substantial doubt about its ability to continue as a going concern due to insufficient cash.

Exicure, Inc. reported a net income of $3.010 million for the first quarter of 2025, primarily due to a significant gain from early lease termination, as the company continues its strategic shift into new business areas while facing substantial doubt about its ability to continue as a going concern.

Exicure Inc. reported its third quarter 2024 results, highlighting a strategic shift towards exploring new opportunities while facing significant financial challenges and going concern doubts.

Exicure Inc. released its Q2 2024 results, highlighting a strategic shift towards exploring alternatives and facing significant financial challenges.

Exicure Inc.'s first quarter 2024 results reveal a company in transition, with a focus on strategic alternatives and facing substantial doubt about its ability to continue as a going concern.

Exicure, Inc. has entered into agreements to secure $2 million in convertible bond financing to support working capital needs as it explores strategic alternatives.

Exicure, Inc. has filed an amended quarterly report to correct a classification error in research and development expenses and acknowledges substantial doubt about its ability to continue as a going concern.

Exicure Inc. reported its third quarter 2023 results, highlighting a significant strategic shift away from research and development and ongoing financial challenges.

Exicure, Inc. has entered into agreements to secure $2 million in convertible bond financing, while also restating previous financial statements due to expense misclassifications and a change in investment valuation.

Exicure, Inc. has filed an amended 10-Q report to correct a misclassification of approximately $0.6 million in expenses from research and development to general and administrative, revealing a material weakness in internal controls.